HOME
 

Regulatory Strategy for a New Active Substance: Global Clinical Development

The Organisation for Professionals in Regulatory Affairs
Course summary
3 days
1,700 GBP excl. VAT
English
Chesham

Course description

Regulatory Strategy for a New Active Substance: Global Clinical Development

This Masterclass is designed for regulatory affairs professionals to develop and deepen their understanding of all aspects of global clinical development. It will allow them to examine the regulatory requirements imposed on clinical development, the processes of preparing documentation for clinical study reports and regulatory overview/summary documents, and strategic considerations for the running of international clinical trial programmes. Lectures and workshops will cover the understanding and application of modern approaches and understanding of designing the clinical programme, different types of studies (pivotal studies, dose-finding, special studies) trial designs, statistical input (intention to treat, efficacy populations), pharmacoeconomics, clinical trial application strategy, special populations (paediatric, elderly, organ impairment) preclinical requirements, territories, (trial locations: diseases prevalence, patient populations, medical expertise) writing and evaluating clinical reports and summaries, risk management, and evaluating the data at the regulatory authorities, and achieving a Global Clinical Programme dossier.

The use of case studies and workshops will assist in the achievement of these learning outcomes and enable the students to contextualise their understanding and knowledge.

Suitability - Who should attend?

Suitable for

  • Students of the MSc programme
  • participants from the regulatory affairs industry who wish to develop their knowledge of the requirements for global clinical development
  • participants from allied industries who wish to have a comprehensive understanding of the subject

Outcome / Qualification etc.

Benefits to participants

This course will enable you to:

  • Possess a systematic understanding of knowledge and a critical awareness of the regulations and international directives pertaining to clinical development of a new medicine
  • Show a critical awareness of the clinical programme strategies which can be employed during development and registration of a new medicine of clinical programme strategy, and effective regulatory leadership throughout the clinical development and the registration of a new medicine
  • Display a comprehensive understanding of the EU Legislation on the different aspects of clinical development and of the procedures and regulatory requirements for clinical trial reports, clinical overview and summary documents for optimal product labelling
  • Evaluate methodologies and develop critique of the medical, statistical, economic and operational aspects of clinical trial programmes
  • Demonstrate the ability to critically analyse the legal documentation global operational clinical trial programme considerations of clinical research
  • Deal with complex issues both systematically and creatively, make sound judgements in the absence of complete data and communicate their conclusions clearly to specialist and non-specialist audiences
  • Critically appraise and evaluate global clinical research communications from regulatory bodies and research publications

Training Course Content

  • Lecture 1: Strategy for a Global Development
  • Lecture 2: The Clinical Trial Programme
  • Lecture 3: Overview of Requirements for Clinical Trials
  • Lecture 4: Ethnic Factors and Clinical Strategies for Non-ICH Markets
  • Lecture 5: The Statistical Input
  • Lecture 6 : Paediatrics and other Special Populations
  • Lecture 7: Unconventional Study Designs
  • Lecture 8: Philosophies and Assessment Techniques of the Regulatory Authorities
  • Lecture 9: Pharmacoeconomics Studies
  • Lecture 10: Clinical Study Reports – Strategic Importance
  • Lecture 11: Clinical Summary Documentation
  • Lecture 12: Pharmacovigilance Strategies
  • Lecture 13: Pharmacogenetics/Pharmacogenomics
  • Lecture 14: Common Faults in Clinical Registration Packages An agency view of clinical documentation

Expenses

The full tuition price for students is 1500 GBP. The price for participants is 1700 GBP

About provider

The Organisation for Professionals in Regulatory Affairs

The Organisation for Professionals in Regulatory Affairs (TOPRA)

The Organisation for Professionals in Regulatory Affairs (TOPRA) has encouraged excellence in the area of regulatory affairs for pharmaceuticals, veterinary medicines and medical devices since 1978. TOPRA's mission is to represent and promote the profession of healthcare regulatory affairs globally....


Read more and show all courses with this provider

Request info

Fill out your details to find out more about Regulatory Strategy for a New Active Substance: Global Clinical Development.

  Contact the provider

  Get more information

  Register your interest

Contact info

The Organisation for Professionals in Regulatory Affairs

3 Harbour Exchange, 6th Floor
E14 9GE London

 Show phone number


Request information

Find out more about this Regulatory Strategy for a New Active Substance: Global Clinical Development course - simply fill out your details:

U.K. L&D Report: 2018 - Benchmark Your Workplace Learning Strategy

Are you curious about the L&D strategies of some of the U.K.'s top companies?

Find out what they're up to in findcourses.co.uk's second annual U.K. L&D Report!

uk-ld-report-2019

Learn more

Find a course for you!

  Read the course
 summary on this page

 Fill in your details and Request information

 Receive all the info you need

Find more courses here